These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 39092767)
1. m6A modification of VEGFA mRNA by RBM15/YTHDF2/IGF2BP3 contributes to angiogenesis of hepatocellular carcinoma. Xu X; Wu S; Zhang Y; Fan W; Lin X; Chen K; Lin X Mol Carcinog; 2024 Nov; 63(11):2174-2189. PubMed ID: 39092767 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis B Virus Small Envelope Protein Promotes Hepatocellular Carcinoma Angiogenesis via Endoplasmic Reticulum Stress Signaling To Upregulate the Expression of Vascular Endothelial Growth Factor A. Wu SX; Ye SS; Hong YX; Chen Y; Wang B; Lin XJ; Lin X J Virol; 2022 Feb; 96(4):e0197521. PubMed ID: 34910612 [TBL] [Abstract][Full Text] [Related]
3. LAGE3 promotes angiogenesis on hepatocellular carcinoma by stabilizing VEGFA mRNA. Cong Z; Zhao H; Zhang S; You T; Xie Y Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167196. PubMed ID: 38653358 [TBL] [Abstract][Full Text] [Related]
4. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma. Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468 [TBL] [Abstract][Full Text] [Related]
5. MiR-497 suppresses angiogenesis and metastasis of hepatocellular carcinoma by inhibiting VEGFA and AEG-1. Yan JJ; Zhang YN; Liao JZ; Ke KP; Chang Y; Li PY; Wang M; Lin JS; He XX Oncotarget; 2015 Oct; 6(30):29527-42. PubMed ID: 26336827 [TBL] [Abstract][Full Text] [Related]
6. RBM15 facilitates laryngeal squamous cell carcinoma progression by regulating TMBIM6 stability through IGF2BP3 dependent. Wang X; Tian L; Li Y; Wang J; Yan B; Yang L; Li Q; Zhao R; Liu M; Wang P; Sun Y J Exp Clin Cancer Res; 2021 Feb; 40(1):80. PubMed ID: 33637103 [TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA UBE2CP3 enhances HCC cell secretion of VEGFA and promotes angiogenesis by activating ERK1/2/HIF-1α/VEGFA signalling in hepatocellular carcinoma. Lin J; Cao S; Wang Y; Hu Y; Liu H; Li J; Chen J; Li P; Liu J; Wang Q; Zheng L J Exp Clin Cancer Res; 2018 Jun; 37(1):113. PubMed ID: 29866133 [TBL] [Abstract][Full Text] [Related]
8. RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer. Yang Z; Wang T; Wu D; Min Z; Tan J; Yu B J Exp Clin Cancer Res; 2020 Sep; 39(1):203. PubMed ID: 32993738 [TBL] [Abstract][Full Text] [Related]
9. YTHDF2 promotes the liver cancer stem cell phenotype and cancer metastasis by regulating OCT4 expression via m6A RNA methylation. Zhang C; Huang S; Zhuang H; Ruan S; Zhou Z; Huang K; Ji F; Ma Z; Hou B; He X Oncogene; 2020 Jun; 39(23):4507-4518. PubMed ID: 32366907 [TBL] [Abstract][Full Text] [Related]
10. Dual effects of targeting neuropilin-1 in lenvatinib-resistant hepatocellular carcinoma: inhibition of tumor growth and angiogenesis. Ao J; Qiang N; Kanzaki H; Nakamura M; Kakiuchi R; Zhang J; Kojima R; Koroki K; Inoue M; Kanogawa N; Nakagawa R; Kondo T; Ogasawara S; Nakamoto S; Muroyama R; Kato J; Kato N Am J Physiol Cell Physiol; 2024 Oct; 327(4):C1150-C1161. PubMed ID: 39250819 [TBL] [Abstract][Full Text] [Related]
11. Evodiamine exerts anti-tumor effects against hepatocellular carcinoma through inhibiting β-catenin-mediated angiogenesis. Shi L; Yang F; Luo F; Liu Y; Zhang F; Zou M; Liu Q Tumour Biol; 2016 Sep; 37(9):12791-12803. PubMed ID: 27449032 [TBL] [Abstract][Full Text] [Related]
12. Activation of YAP1 by N6-Methyladenosine-Modified circCPSF6 Drives Malignancy in Hepatocellular Carcinoma. Chen Y; Ling Z; Cai X; Xu Y; Lv Z; Man D; Ge J; Yu C; Zhang D; Zhang Y; Xie H; Zhou L; Wu J; Zheng S Cancer Res; 2022 Feb; 82(4):599-614. PubMed ID: 34916222 [TBL] [Abstract][Full Text] [Related]
13. Silencing of long noncoding RNA LEF1-AS1 prevents the progression of hepatocellular carcinoma via the crosstalk with microRNA-136-5p/WNK1. Dong H; Jian P; Yu M; Wang L J Cell Physiol; 2020 Oct; 235(10):6548-6562. PubMed ID: 32068261 [TBL] [Abstract][Full Text] [Related]
14. Parecoxib inhibits tumorigenesis and angiogenesis in hepatocellular carcinoma through ERK-VEGF/MMPs signaling pathway. Tian L; Huang Y; Liu Y; Liu J; Liu Y IUBMB Life; 2024 Nov; 76(11):972-986. PubMed ID: 38873890 [TBL] [Abstract][Full Text] [Related]
15. YTHDF3-mediated m6A modification of NKD1 regulates hepatocellular carcinoma invasion and metastasis by activating the WNT/β-catenin signaling axis. Chen S; Wang L; Xu Z; Chen L; Li Q; Zhong F; Tang N; Song J; Zhou R Exp Cell Res; 2024 Sep; 442(1):114192. PubMed ID: 39127439 [TBL] [Abstract][Full Text] [Related]
16. BMP9-ID1 Signaling Activates HIF-1α and VEGFA Expression to Promote Tumor Angiogenesis in Hepatocellular Carcinoma. Chen H; Nio K; Tang H; Yamashita T; Okada H; Li Y; Doan PTB; Li R; Lv J; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Kaneko S Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163396 [TBL] [Abstract][Full Text] [Related]
17. Circ_0098823 binding with IGF2BP3 regulates DNM1L stability to promote metastasis of hepatocellular carcinoma via mitochondrial fission. Yan J; Wang X; Fan Z; Xu Y; Zhang Y; Liu Y; Guo L; Liu D Apoptosis; 2024 Jun; 29(5-6):709-725. PubMed ID: 38459420 [TBL] [Abstract][Full Text] [Related]
18. METTL5 enhances the mRNA stability of TPRKB through m Luo M; Luo X; Sun J; Ao X; Han H; Yang X Exp Cell Res; 2024 Sep; 442(1):114219. PubMed ID: 39182664 [TBL] [Abstract][Full Text] [Related]
19. miR-451 acts as a suppressor of angiogenesis in hepatocellular carcinoma by targeting the IL-6R-STAT3 pathway. Liu X; Zhang A; Xiang J; Lv Y; Zhang X Oncol Rep; 2016 Sep; 36(3):1385-92. PubMed ID: 27461244 [TBL] [Abstract][Full Text] [Related]
20. The transcription factor ZFHX3 is crucial for the angiogenic function of hypoxia-inducible factor 1α in liver cancer cells. Fu C; An N; Liu J; A J; Zhang B; Liu M; Zhang Z; Fu L; Tian X; Wang D; Dong JT J Biol Chem; 2020 May; 295(20):7060-7074. PubMed ID: 32277050 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]